Abstract:Xiao-yu Liang, 1 Fen-Fang Hong, 2 Shu-Long Yang 1 1 Department of Physiology, College of Medicine, Nanchang University, Nanchang, 330006, People's Republic of China; 2 Experimental Teaching Center, Nanchang University, Nanchang, 330031, People's Republic of China Correspondence: Shu-Long Yang Department of Physiology, College of Medicine, Nanchang University, Nanchang, 330006, People's Republic of China Tel +86 13576291532 Email Fen-Fang Hong Experimental Teaching Center, Nanchang University, Nanchang, 330031, People's Republic of China Tel +86 18970965319 Email Purpose: Non-alcoholic fatty liver disease (NAFLD) is the main form of chronic liver disease in the world. Astragaloside IV (ASIV) has been tested in experimental models of different diseases. The purpose of this study was to evaluate the effect and protective mechanism of ASIV on NAFLD. Methods: Lipopolysaccharide (LPS)- and palmitate acid (PA)-induced RAW264.7 cells and LO2 cells were used as a NAFLD model. The mice NAFLD model was evaluated by hematoxylin-eosin staining (HE staining), and aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels. Liver lipid metabolism was evaluated by triglyceride (TG) and total cholesterol (TC) kits and oil red O staining. Oxidative stress indicators were examined through biochemical methods. Inflammatory factors were explored through enzyme-linked immuno sorbent assay (ELISA), real-time quantitative PCR and oxidative stress indicator kits. The expression levels of 5-LO (5-lipoxygenase) and leukotriene A4 hydrolase (LTA4H) were checked by real-time quantitative PCR and Western blotting. Apoptosis was detected by Annexin V-FITC/PI cell apoptosis detection kit. Results: Our results showed that in vivo ASIV significantly reduced liver tissue damage, and serum AST, ALT and serum TG levels in NAFLD mice. In vitro, ASIV reduced cell supernatant TG and TC content increased by PA treatment, and significantly decreased the accumulation of intracellular lipid droplets induced by PA treatment. Additionally, ASIV reduced reactive oxygen species (ROS) and malondialdehyde (MDA) levels, and restored glutathione peroxidase (GSH-Px) levels in PA-treated LO2 cell supernatant. Furthermore, ASIV inhibited the production of proinflammatory cytokines (IL-6 and TNF-α) in RAW264.7 cells induced by LPS. We also found that ASIV downregulated the expression of 5-LO and LTB4 (leukotriene B4) in NAFLD mice. Moreover, ASIV restored apoptotic protein (Bax and Bcl-2) expression in PA-treated LO2 cells. Conclusion: ASIV may reduce liver steatosis, hepatocyte oxidative stress and apoptosis, and decrease liver inflammation, thereby attenuating the progression of NAFLD and thus might be of therapeutic interest. Keywords: astragaloside IV, non-alcoholic fatty liver disease, lipid accumulation, oxidative stress, apoptosis Non-alcoholic fatty liver disease (NAFLD) is an emerging health problem worldwide, with significantly increasing morbidity in the past two decades. 1 , 2 NAFLD covers the disease spectrum from isolated hepatic steatosis (simple steatosis) to non-alcoholic steatohepatitis (NASH), which is characterized by hepatocellular damage, persistent liver inflammation and fibrosis, and eventually develops into cirrhosis and liver cell carcinoma (HCC). 3 , 4 Simple steatosis is a relatively benign disease, and the pathological and biological processes of its evolution into NASH are complex and multiphase. 5 , 6 Development of NAFLD involves multiple pathogenic factors such as fat accumulation, lipotoxicity, inflammation, oxidative stress and mitochondrial dysfunction. 7 Feeding high fat diet (HFD) has been recognized to cause liver steatosis and inflammation in experimental mice, and there is obvious oxidative damage in the liver. 8 It has been reported that mice fed a HFD for 12–16 weeks can replicate the histopathological and pathogenic characteristics of NAFLD. 9 Fat accumulation in the liver results from the increased uptake of circulating lipids, increased nascent lipid production, and impaired fatty acid oxidation. 10 Many studies have shown that saturated fatty acids, especially palmitic acid (PA), are the most abundant free fatty acids (FFA) in the diet and serum which can increase liver fat and insulin resistance. Additionally, these FFA can activate endoplasmic reticulum stress and accelerate mitochondrial metabolism. 11 , 12< -Abstract Truncated-

Effect of Atractylodes lancea on nonalcoholic fatty liver disease rat induced by high fat - high fructose diet

Effect of Atractylodes lancea on Cardio-Renal Function in High-Fat-High-Fructose Diet Induced Metabolic Syndrome Rats

Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway

Therapeutic potential of alkaloid extract from Codonopsis Radix in alleviating hepatic lipid accumulation: insights into mitochondrial energy metabolism and endoplasmic reticulum stress regulation in NAFLD mice

α-lipoic acid prevents non-alcoholic fatty liver disease in OLETF rats

Protective effects of the Alisma orientalis extract on the experimental nonalcoholic fatty liver disease

Assessing the in vivo ameliorative effects of Lactobacillus acidophilus KLDS1.0901 for induced non-alcoholic fatty liver disease treatment

3-Acetyl-oleanolic acid ameliorates non-alcoholic fatty liver disease in high fat diet-treated rats by activating AMPK-related pathways

The therapeutic effect of alcoholic extract of Fumaria parviflora on high-fat diet-induced nonalcoholic fatty liver in rats: an animal experiment

Alantolactone attenuates high-fat diet-induced inflammation and oxidative stress in non-alcoholic fatty liver disease

Atractylodin alleviates nonalcoholic fatty liver disease by regulating Nrf2-mediated ferroptosis

Astragaloside IV Alleviates Liver Inflammation, Oxidative Stress and Apoptosis to Protect Against Experimental Non-Alcoholic Fatty Liver Disease

Indole Alkaloids of Alstonia Scholaris (L.) R. Br. Alleviated Nonalcoholic Fatty Liver Disease in Mice Fed with High-Fat Diet

A novel Alisma orientale extract alleviates non-alcoholic steatohepatitis in mice via modulation of PPARα signaling pathway

Beneficial Activities of Alisma orientale Extract in a Western Diet-Induced Murine Non-Alcoholic Steatohepatitis and Related Fibrosis Model via Regulation of the Hepatic Adiponectin and Farnesoid X Receptor Pathways

Astaxanthin Alleviates Nonalcoholic Fatty Liver Disease by Regulating the Intestinal Flora and Targeting the AMPK/Nrf2 Signal Axis

Supplementation of Lactobacillus Plantarum ATCC14917 Mitigates Non-Alcoholic Fatty Liver Disease in High-Fat-diet-fed Rats

Polysaccharide of Atractylodes macrocephala Koidz alleviates NAFLD-induced hepatic inflammation in mice by modulating the TLR4/MyD88/NF-κB pathway

The Glycyrrhiza Glabra L. Crude Extract Alleviates Lipid Accumulation in NAFLD by Activating Nrf2 and Promoting Autophagy

Agastache rugosa alleviates the multi-hit effect on hepatic lipid metabolism, inflammation and oxidative stress during nonalcoholic fatty liver disease

Beneficial Effects of Dietary Flaxseed on Non-Alcoholic Fatty Liver Disease